THOMAS F. DEUEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENZON PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2011-04-08 Dr. Deuel is currently a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute.
2012-04-06 Dr. Deuel is a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, and has an M.D. from Columbia University and an A.B. from Princeton University.

Data sourced from SEC filings. Last updated: 2025-07-01